"Benzylidene Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds containing the PhCH= radical.
Below are MeSH descriptors whose meaning is more general than "Benzylidene Compounds".
Below are MeSH descriptors whose meaning is more specific than "Benzylidene Compounds".
This graph shows the total number of publications written about "Benzylidene Compounds" by people in this website by year, and whether "Benzylidene Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Benzylidene Compounds" by people in Profiles.
Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells. Immunobiology. 2020 03; 225(2):151886.
Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24. Am J Physiol Gastrointest Liver Physiol. 2018 08 01; 315(2):G318-G327.
Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model. Neuropharmacology. 2015 Dec; 99:318-27.
Therapeutic potential of curcumin and curcumin analogues in rheumatology. Int J Rheum Dis. 2015 Jul; 18(6):591-3.
The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model. Scand J Trauma Resusc Emerg Med. 2015 Feb 03; 23:8.
Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA. J Pharmacol Exp Ther. 2014 Nov; 351(2):413-22.
Hemorrhage-induced interleukin-1 receptor pathway in lung is suppressed by 3,5-bis(2-fluorobenzylidene)-4-piperidone in a rat model of hypovolemic shock. Artif Organs. 2014 Aug; 38(8):675-83.
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft. Br J Pharmacol. 2013 Dec; 170(7):1436-48.
Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival. J Pharmacol Exp Ther. 2013 Nov; 347(2):346-56.
Novel synthetic monoketone transmute radiation-triggered NF?B-dependent TNFa cross-signaling feedback maintained NF?B and favors neuroblastoma regression. PLoS One. 2013; 8(8):e72464.